B78.9
Strongyloidiasis, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Strongyloidiasis is an intestinal infection caused by the parasitic roundworm Strongyloides stercoralis. This condition is prevalent in tropical and subtropical regions but can also be found in other parts of the world. When the specific type of strongyloidiasis cannot be determined, it is classified under the ICD-10 code B78.9, indicating an unspecified infection of the same parasitic species. Understanding this condition helps in recognizing its causes, symptoms, and potential treatment options.
Causes & Symptoms
Clinical Causes: Contact with soil contaminated with infective larvae of Strongyloides stercoralis. Walking barefoot or having skin contact with contaminated soil or water. Relying on sanitation practices that are inadequate, leading to the spread of the parasite. Transmission through ingestion of contaminated food or water. Reverse autoinfection, where the parasite re-enters the body through the intestinal wall, prolonging infection.
Key Symptoms: Abdominal pain or discomfort. Diarrhea or constipation. Nausea and vomiting. Unexplained weight loss. Persistent cough or respiratory symptoms if the larvae migrate to the lungs. Skin rash or itching, especially around the buttocks or thighs. Weakness and fatigue. In severe cases or in immunocompromised individuals, signs of disseminated strongyloidiasis such as fever, gram-negative bacteremia, and widespread organ involvement.
Diagnostic & Treatment
Diagnosis Path: Diagnosing strongyloidiasis can involve several methods, including:
Treatment Protocols: Effective management of strongyloidiasis involves antiparasitic medications, among which ivermectin and albendazole are most commonly prescribed. Treatment considerations include:
Clinical Advice & FAQs
Billing Guidance
Is B78.9 a billable ICD-10 code?
Yes, B78.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B78.9?
Clinical documentation must specify the nature of Strongyloidiasis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference